PTK2 and nonpapillary renal cell carcinoma: (b) Integrin α7 might regulate multiple pathways (including the corresponding FAK/MAPK/ERK pathway) to increase stemness of cancer cells, subsequently enhancing the abilities to self‐renew, differentiate and chemoresistance, which caused poor survival in ccRCC patients.